Inhibition mechanism of membrane metalloprotease by an exosite-swiveling conformational antibody.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Structure

• Publication date

  2014-12-17

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.str.2014.10.012PMID 25482542
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Unraveling hidden regulatory sites in structurally homologous metalloproteases.

  2013cited by this paper
• New approaches for dissecting protease functions to improve probe development and drug discovery

  2012cited by this paper
• Site-specific cellular functions of MT1-MMP.

  2012cited by this paper
• The protease MT1‐MMP drives a combinatorial proteolytic program in activated endothelial cells

  2012cited by this paper
• Protease-Activated Drug Development

  2012cited by this paper
• Correlated structural kinetics and retarded solvent dynamics at the metalloprotease active site

  2011cited by this paper
• NMR and Bioinformatics Discovery of Exosites That Tune Metalloelastase Specificity for Solubilized Elastin and Collagen Triple Helices*

  2010cited by this paper
• Golgi reassembly stacking protein 55 interacts with membrane‐type (MT) 1‐matrix metalloprotease (MMP) and furin and plays a role in the activation of the MT1‐MMP zymogen

  2010cited by this paper
• The intrinsic protein flexibility of endogenous protease inhibitor TIMP-1 controls its binding interface and affects its function.

  2010cited by this paper
• Structural and functional bases for allosteric control of MMP activities: can it pave the path for selective inhibition?

  2010cited by this paper
• Matrix metalloproteinase proteomics: substrates, targets, and therapy.

  2009cited by this paper
• MMP-12 Catalytic Domain Recognizes Triple Helical Peptide Models of Collagen V with Exosites and High Activity*

  2008cited by this paper
• Intrinsic dynamics of enzymes in the unbound state and relation to allosteric regulation.

  2007cited by this paper
• Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice.

  2007cited by this paper
• Emerging roles of proteases in tumour suppression

  2007cited by this paper
• Key feature of the catalytic cycle of TNF-α converting enzyme involves communication between distal protein sites and the enzyme catalytic core

  2007cited by this paper
• Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

  2006cited by this paper
• Targeting proteases: successes, failures and future prospects

  2006cited by this paper
• Recent advances in MMP inhibitor design

  2006cited by this paper
• Cell surface collagenolysis requires homodimerization of the membrane-bound collagenase MT1-MMP.

  2006cited by this paper
• MT1-MMP: Universal or particular player in angiogenesis?

  2006cited by this paper
• Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy

  2006cited by this paper
• Recombinant protein secretion in Escherichia coli.

  2005cited by this paper
• Pivotal molecular determinants of peptidic and collagen triple helicase activities reside in the S3' subsite of matrix metalloproteinase 8 (MMP-8): the role of hydrogen bonding potential of ASN188 and TYR189 and the connecting cis bond.

  2005cited by this paper
• Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs.

  2005cited by this paper
• Recent developments in the design of specific Matrix Metalloproteinase inhibitors aided by structural and computational studies.

  2005cited by this paper
• Is allostery an intrinsic property of all dynamic proteins?

  2004cited by this paper
• Co-recycling of MT1-MMP and MT3-MMP through the Trans-Golgi Network

  2004cited by this paper
• Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion.

  2003cited by this paper
• Phase speciation by extended x-ray absorption fine structure spectroscopy

  2002cited by this paper
• Proteomics and Models for Enzyme Cooperativity* 210

  2002cited by this paper
• Protease degradomics: A new challenge for proteomics

  2002cited by this paper
• Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations

  2002cited by this paper
• Matrix metalloproteinases: a tail of a frog that became a prince

  2002cited by this paper
• Strategies for MMP inhibition in cancer: innovations for the post-trial era

  2002cited by this paper
• Molecular determinants of metalloproteinase substrate specificity

  2002cited by this paper
• Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors.

  2002cited by this paper
• The cytoplasmic tail peptide sequence of membrane type‐1 matrix metalloproteinase (MT1‐MMP) directly binds to gC1qR, a compartment‐specific chaperone‐like regulatory protein

  2002cited by this paper
• Cytoplasmic tail–dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity

  2001cited by this paper
• Membrane Type 1-Matrix Metalloproteinase Is Activated during Migration of Human Endothelial Cells and Modulates Endothelial Motility and Matrix Remodeling*

  2001cited by this paper
• Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis

  2001cited by this paper
• Regulation of Membrane-type-1 Matrix Metalloproteinase Activity by Its Cytoplasmic Domain*

  2000cited by this paper
• Unraveling the role of proteases in cancer.

  2000cited by this paper
• Identification of the 183RWTNNFREY191Region as a Critical Segment of Matrix Metalloproteinase 1 for the Expression of Collagenolytic Activity*

  2000cited by this paper
• Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.

  2000cited by this paper
• Matrix Metalloproteinases*

  1999cited by this paper
• A phosphorylation-induced major structural change in the N-terminal domain of the P protein of Chandipura virus.

  1999cited by this paper
• Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense.

  1999cited by this paper
• The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A

  1998cited by this paper
• Temperature-induced conformational transition of intestinal fatty acid binding protein enhancing ligand binding: a functional, spectroscopic, and molecular modeling study.

  1998cited by this paper
• Crystal structure of the complex formed by the membrane type 1‐matrix metalloproteinase with the tissue inhibitor of metalloproteinases‐2, the soluble progelatinase A receptor

  1998cited by this paper
• Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion.

  1997cited by this paper
• Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat.

  1997cited by this paper
• Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation

  1996cited by this paper
• Matrilysin-inhibitor complexes: common themes among metalloproteases.

  1996cited by this paper
• Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase

  1995cited by this paper
• Crystal structures of matrilysin-inhibitor complexes

  1995cited by this paper
• Antibody-antigen interactions: new structures and new conformational changes.

  1994cited by this paper
• A matrix metalloproteinase expressed on the surface of invasive tumour cells

  1994cited by this paper
• Protease inhibitors: role and potential therapeutic use in human cancer.

  1994cited by this paper
• Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc‐binding environments (HEXXHXXGXXH and Met‐turn) and topologies and should be grouped into a common family, the ‘metzincins’

  1993cited by this paper
• Pulse sequences for removal of the effects of cross correlation between dipolar and chemical-shift anisotropy relaxation mechanisms on the measurement of heteronuclear T1 and T2 values in proteins

  1992cited by this paper
• A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases

  1992cited by this paper
• Conformations of immunoglobulin hypervariable regions

  1989cited by this paper
• ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL.

  1965cited by this paper

• Matrix Metalloproteinase 14 in Corneal Neovascularization.

  2026cites this paper
• Engineered protein inhibitors for precise targeting of matrix metalloproteinases.

  2025cites this paper
• Extracellular matrix and proteolysis: mechanisms driving irreversible changes and shaping cell behavior.

  2025cites this paper
• Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy.

  2024cites this paper
• Extracellular matrix metalloproteinases in pathophysiology, diagnostics and treatment of renal cell carcinoma - current state of knowledge and future perspectives.

  2024cites this paper
• Regulation of Peptidase Activity beyond the Active Site in Human Health and Disease

  2023cites this paper
• Computational design of Matrix Metalloprotenaise-9 (MMP-9) resistant to autocleavage

  2023cites this paper
• Designed loop extension followed by combinatorial screening confers high specificity to a broad matrix metalloproteinaseinhibitor.

  2023cites this paper
• The tetrapartite synapse in neuropsychiatric disorders: Matrix metalloproteases (MMPs) as promising targets for treatment and rational drug design.

  2022cites this paper
• A broad matrix metalloproteinase inhibitor with designed loop extension exhibits ultrahigh specificity for MMP-14

  2022cites this paper
• Synthesis and In Vivo Evaluation of a Site-specifically Labeled Radioimmunoconjugate for Dual-Modal (PET/NIRF) Imaging of MT1-MMP in Sarcomas

  2022cites this paper
• Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology

  2022cites this paper
• Novel immunotherapy strategies involving matrix metalloproteinase (MMP) family

  2021cites this paper
• Key Matrix Remodeling Enzymes: Functions and Targeting in Cancer

  2021cites this paper
• Serum of Mice Immunized with MT1-MMP Metalloproteinase Reduces Migration Potential of Pancreatic Cancer Cells

  2021cites this paper
• Membrane-type I matrix metalloproteinase (MT1-MMP), lipid metabolism, and therapeutic implications

  2021cites this paper
• LOXL2 Inhibition Paves the Way for Macrophage-Mediated Collagen Degradation in Liver Fibrosis

  2020cites this paper
• Matrix metalloproteinase-14 regulates collagen degradation and migration of mononuclear cells during infection with genotype VII Newcastle disease virus.

  2020cites this paper
• Matrix Metalloproteinases as New Targets in Alzheimer's Disease: Opportunities and Challenges.

  2020cites this paper
• Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics

  2020cites this paper
• Challenges with matrix metalloproteinase inhibition and future drug discovery avenues

  2020cites this paper
• ASAP-SML: An antibody sequence analysis pipeline using statistical testing and machine learning

  2020cites this paper
• Protease Inhibition Mechanism of Camelid-like Synthetic Human Antibodies.

  2020cites this paper
• Generation of highly selective monoclonal antibodies inhibiting a recalcitrant protease using decoy designs

  2020cites this paper
• The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors

  2020influential citation
• Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation

  2019cites this paper
• Monoclonal antibodies against metzincin targets

  2019cites this paper
• Mechanism and Inhibition of Matrix Metalloproteinases.

  2019cites this paper
• Targeting Matrix Metalloproteinases for Diabetic Retinopathy: The Way Ahead?

  2019cites this paper
• The membrane tethered matrix metalloproteinase MT1-MMP triggers an outside-in DNA damage response that impacts chemo- and radiotherapy responses of breast cancer.

  2019cites this paper
• Recent advances in understanding the roles of matrix metalloproteinases in tumour invasion and metastasis

  2019cites this paper
• A DNA aptamer recognizing MMP14 for in vivo and in vitro imaging identified by cell-SELEX

  2019cites this paper
• Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases

  2019cites this paper
• The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma

  2019cites this paper
• The past, present and future perspectives of matrix metalloproteinase inhibitors.

  2019cites this paper
• Tracking the Cartoon mouse phenotype: Hemopexin domain–dependent regulation of MT1-MMP pericellular collagenolytic activity

  2018cites this paper
• Roles of Pericellular Proteases in Tumor Angiogenesis: Therapeutic Implications

  2018cites this paper
• Epitope‐specific affinity maturation improved stability of potent protease inhibitory antibodies

  2018cites this paper
• MT1-MMP as a PET Imaging Biomarker for Pancreas Cancer Management

  2018cites this paper
• Metalloproteinases in Rheumatoid Arthritis: Potential Therapeutic Targets to Improve Current Therapies.

  2017cites this paper
• Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases.

  2017cites this paper
• Matrix metalloproteinase collagenolysis in health and disease.

  2017cites this paper
• Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.

  2017cites this paper
• Cross-recognition of a pit viper (Crotalinae) polyspecific antivenom explored through high-density peptide microarray epitope mapping

  2017cites this paper
• Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution*

  2017cites this paper
• Identification of highly selective MMP‐14 inhibitory Fabs by deep sequencing

  2017cites this paper
• Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer

  2017cites this paper
• The Roles of Matrix Metalloproteinases in Pancreatic Cancer.

  2017cites this paper
• Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas

  2016cites this paper
• Syddansk Universitet Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivo Botkjaer,

  2016cites this paper
• Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivo

  2016cites this paper
• The membrane tethered matrix metalloproteinase MT1-MMP at the forefront of melanoma cell invasion and metastasis.

  2016cites this paper
• Extracellular Matrix Proteolysis by MT1-MMP Contributes to Influenza-Related Tissue Damage and Mortality.

  2016cites this paper
• Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis

  2016cites this paper
• Nonproteolytic functions of matrix metalloproteinases in pathology and insights for the development of novel therapeutic inhibitors

  2015cites this paper
• Extracellular Juxtamembrane Segment of ADAM17 Interacts with Membranes and Is Essential for Its Shedding Activity.

  2015cites this paper
• Renaissance of MMPs as therapeutic targets? Maybe.

  2015cites this paper